Zacks Research Issues Optimistic Estimate for ENSG Earnings

The Ensign Group, Inc. (NASDAQ:ENSG) – Zacks Research raised their FY2026 earnings per share estimates for shares of The Ensign Group in a note issued to investors on Tuesday, November 10th. Zacks Research analyst Team now forecasts that the company will earn $7.10 per share for the year, up from their previous estimate of $6.98. The consensus estimate for The Ensign Group’s current full-year earnings is $7.07 per share. Zacks Research also issued estimates for The Ensign Group’s Q4 2026 earnings at $1.92 EPS, Q1 2027 earnings at $1.81 EPS, Q2 2027 earnings at $1.73 EPS, Q3 2027 earnings at $1.91 EPS, Q4 2027 earnings at $1.88 EPS, FY2027 earnings at $7.32 EPS, Q1 2028 earnings at $2.07 EPS, Q2 2028 earnings at $1.87 EPS, Q3 2028 earnings at $2.10 EPS and FY2028 earnings at $8.16 EPS.

The Ensign Group (NASDAQ:ENSG) last issued its quarterly earnings results on Tuesday, October 27th. The company reported $2.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.97 by $0.06. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.51 billion. The Ensign Group had a return on equity of 16.79% and a net margin of 7.03%. The Ensign Group’s revenue was up 14.5% on a year-over-year basis. During the same period last year, the company earned $1.64 earnings per share.

ENSG has been the subject of several other research reports. Oppenheimer raised their target price on shares of The Ensign Group from $210.00 to $215.00 and gave the stock an “outperform” rating in a report on Thursday, October 29th. UBS Group reiterated a “buy” rating and set a $240.00 price target (up from $230.00) on shares of The Ensign Group in a report on Thursday, October 29th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a research report on Sunday, October 25th. Weiss Ratings raised shares of The Ensign Group from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. Finally, Truist Financial set a $210.00 price objective on shares of The Ensign Group and gave the stock a “hold” rating in a research note on Thursday, October 29th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $226.00.

The Ensign Group Trading Up 0.6%

ENSG stock opened at $186.19 on Thursday. The Ensign Group has a twelve month low of $141.58 and a twelve month high of $218.00. The stock has a market capitalization of $10.86 billion, a price-to-earnings ratio of 27.71, a price-to-earnings-growth ratio of 1.75 and a beta of 0.66. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.08. The firm’s fifty day simple moving average is $175.91 and its two-hundred day simple moving average is $181.79.

Institutional Trading of The Ensign Group

A number of hedge funds and other institutional investors have recently bought and sold shares of ENSG. BlackRock Inc. bought a new stake in shares of The Ensign Group during the second quarter worth $937,218,000. Wasatch Advisors LP boosted its stake in shares of The Ensign Group by 10.7% during the second quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company’s stock valued at $365,215,000 after purchasing an additional 220,329 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in shares of The Ensign Group by 7.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 457,667 shares of the company’s stock valued at $92,220,000 after purchasing an additional 30,521 shares during the period. Bank of New York Mellon Corp bought a new position in shares of The Ensign Group in the second quarter worth about $65,470,000. Finally, Paradigm Capital Management Inc. NY bought a new position in shares of The Ensign Group in the second quarter worth about $54,742,000. Hedge funds and other institutional investors own 96.12% of the company’s stock.

The Ensign Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Saturday, October 31st. Shareholders of record on Wednesday, September 30th were given a $0.0650 dividend. This represents a $0.26 annualized dividend and a yield of 0.1%. The ex-dividend date of this dividend was Wednesday, September 30th. The Ensign Group’s dividend payout ratio is 3.87%.

Key Stories Impacting The Ensign Group

Investors following ENSG have been watching these stories:

• Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $7.10 from $6.98 and FY2027 to $7.32 from $7.26. Several quarterly estimates also increased, suggesting a modestly improved near-term earnings outlook.
• Neutral Sentiment: Estimate changes were mixed: Zacks lowered Q3 2027 and Q3 2028 EPS forecasts, and trimmed its FY2028 estimate slightly to $8.16 from $8.19, while raising estimates for other quarters. The revisions do not indicate a consistent change across the full forecast period.
• Negative Sentiment: Law firms are publicizing a pending securities class action against Ensign and a December 7 lead-plaintiff deadline. The case covers investors who acquired shares from February 10, 2022 through June 18, 2026; the legal claims create reputational and potential financial uncertainty, though the notices do not establish wrongdoing. Article: Securities class action notice

The Ensign Group Company Profile

The Ensign Group, Inc. is a healthcare services company focused on post-acute care and senior living. Through its subsidiaries, it operates skilled nursing and rehabilitation facilities, assisted living communities, and independent living communities. The company also provides home health and hospice services, as well as mobile diagnostics and other ancillary services that support patients and care facilities. Its operations serve communities across multiple U.S. states. Founded in 1999, Ensign has grown from a skilled nursing operator into a broader provider of healthcare and senior services.